Trajan Maintains $170M Revenue Guidance as Q2 Hits Record $45.4M
Trajan Scientific and Medical is a global technology company dedicated to advancing scientific measurement and personal health through innovative analytical solutions. Founded in July 2011, the company aims to translate analytical science into tangible tools that directly benefit society by enabling more precise understanding of human health and environmental factors.
As a key provider of engineered components and analytical technologies, Trajan specializes in two primary domains: analytical technologies and life sciences. In the analytical realm, they focus on chromatography and mass spectrometry technologies that enable measurements in biology, food, and environmental sectors. Their expertise lies in producing critical components and materials that enhance laboratory performance and result quality across various scientific workflows.
The company’s life science solutions encompass a wide range of products, including medical devices for microsample collection, premium pathology products, precision components for mass spectrometry, and automated workflow solutions. Trajan is committed to optimizing scientific processes by developing sophisticated systems that can integrate into laboratories and generate custom solutions for research and development. Their overarching mission is to enrich personal health through scientific tools and solutions, emphasizing the critical role of precise measurement in understanding human well-being.
© 2026 StockWire X Pty Ltd. All rights reserved.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.